Stempoint Capital LP owned approximately 0.54% of Evommune worth $4,385,000 at the end of the most recent reporting period. Capricorn Fund Managers Ltd bought a new position in Evommune in the fourth quarter worth approximately $1,027,000. Geode Capital Management LLC purchased a new stake in shares of Evommune in the 4th quarter worth $1,881,000. Finally, Seven Grand Managers LLC bought a new position in shares of Evommune during the 4th quarter worth $1,284,000. In the last ninety days, insiders sold 100,854 shares of company stock worth $2,279,142.